TABLE OF CONTENTS
Volume 68, Issue 1 (July 2005)
Perspectives in Basic Medicine |
Genetic Disorders – Development |
Hormones – Cytokines – Signalling |
Cell Biology – Immunology – Pathology |
Vascular Biology – Hemodynamics – Hypertension |
Clinical Nephrology – Epidemiology – Clinical Trials |
Dialysis – Transplantation |
Technical Note |
Historical Archives |
Editorials |
Letters to the Editor |
Nephrology Forum |
International Society of Nephrology
Perspectives in Renal Medicine
Chronic renal allograft rejection: Pathophysiologic considerations
SIMONE A JOOSTEN, YVO W J SIJPKENS, CEES VAN KOOTEN and LEENDERT C PAUL
Kidney Int 68: 1-13; doi:10.1111/j.1523-1755.2005.00376.x
Perspectives in Basic Medicine
Pathophysiology of contrast medium–induced nephropathy
PONTUS B PERSSON, PETER HANSELL and PER LISS
Kidney Int 68: 14-22; doi:10.1111/j.1523-1755.2005.00377.x
Genetic Disorders – Development
Fish mesonephric model of polycystic kidney disease in medaka (Oryzias latipes) pc mutant
EMIKO MOCHIZUKI, KATSUHIRO FUKUTA, TATSUYA TADA, TOMOHIRO HARADA, NAOKI WATANABE, SEIICHI MATSUO, HISASHI HASHIMOTO, KENJIRO OZATO and YUKO WAKAMATSU
Kidney Int 68: 23-34; doi:10.1111/j.1523-1755.2005.00378.x
Hormones – Cytokines – Signalling
Lipoxin A4 inhibits TNF-
–induced production of interleukins and proliferation of rat mesangial cells
SHENG-HUA WU, CHAO LU, LING DONG, GUO-PING ZHOU, ZHA-GUANG HE and ZI-QING CHEN
Kidney Int 68: 35-46; doi:10.1111/j.1523-1755.2005.00379.x
Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis
YINGRUI WANG, STEPHANIE KRÄMER, TANJA LOOF, SEBASTIAN MARTINI, SUSANNE KRON, HIROSHI KAWACHI, FUIJO SHIMIZU, HANS-H NEUMAYER and HARM PETERS
Kidney Int 68: 47-61; doi:10.1111/j.1523-1755.2005.00380.x
Chemokine response to febrile urinary tract infection
GISELA OTTO, MARIE BURDICK, ROBERT STRIETER and GABRIELA GODALY
Kidney Int 68: 62-70; doi:10.1111/j.1523-1755.2005.00381.x
Cell Biology – Immunology – Pathology
Hyaluronan is apically secreted and expressed by proliferating or regenerating renal tubular cells
MARINO ASSELMAN, ANJA VERHULST, EDDY S VAN BALLEGOOIJEN, CHRIS H BANGMA, CARL F VERKOELEN and MARC E DE BROE
Kidney Int 68: 71-83; doi:10.1111/j.1523-1755.2005.00382.x
Citrullination preferentially proceeds in glomerular Bowman's capsule and increases in obstructive nephropathy
DONGYUN FENG, TOSHIYUKI IMASAWA, TADASUKE NAGANO, MASARU KIKKAWA, KAORI TAKAYANAGI, TAKAKO OHSAWA, KYOICHI AKIYAMA, AKIHITO ISHIGAMI, TOSIFUSA TODA, TETSUYA MITARAI, TAKEO MACHIDA and NAOKI MARUYAMA
Kidney Int 68: 84-95; doi:10.1111/j.1523-1755.2005.00383.x
The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway
MALTE H J HEEG, MICHAEL J KOZIOLEK, RADOVAN VASKO, LILIANA SCHAEFER, KUMAR SHARMA, GERHARD A MÜLLER and FRANK STRUTZ
Kidney Int 68: 96-109; doi:10.1111/j.1523-1755.2005.00384.x
Shedding of endothelial protein C receptor contributes to vasculopathy and renal injury in lupus: In vivo and in vitro evidence
CARLOS A SESIN, XIAOMING YIN, CHARLES T ESMON, JILL P BUYON and ROBERT M CLANCY
Kidney Int 68: 110-120; doi:10.1111/j.1523-1755.2005.00385.x
Kidneys with heavy proteinuria show fibrosis, inflammation, and oxidative stress, but no tubular phenotypic change
ARVI-MATTI KUUSNIEMI, RISTO LAPATTO, CHRISTER HOLMBERG, RIITTA KARIKOSKI, JUHANI RAPOLA and HANNU JALANKO
Kidney Int 68: 121-132; doi:10.1111/j.1523-1755.2005.00386.x
ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo
MICHAEL R VAUGHAN, JEFFREY W PIPPIN, SIÂN V GRIFFIN, RON KROFFT, MARGARET FLEET, LEAH HASELEY and STUART J SHANKLAND
Kidney Int 68: 133-144; doi:10.1111/j.1523-1755.2005.00387.x
Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: Osteopontin localization
ANDREW P EVAN, FREDRIC L COE, SUSAN R RITTLING, SHARON M BLEDSOE, YOUZHI SHAO, JAMES E LINGEMAN and ELAINE M WORCESTER
Kidney Int 68: 145-154; doi:10.1111/j.1523-1755.2005.00388.x
Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs)
KALU U E OGBUREKE and LARRY W FISHER
Kidney Int 68: 155-166; doi:10.1111/j.1523-1755.2005.00389.x
Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy
LI-XIA XU and MING-HUI ZHAO
Kidney Int 68: 167-172; doi:10.1111/j.1523-1755.2005.00390.x
Vascular Biology – Hemodynamics – Hypertension
Carbamylated low-density lipoprotein induces death of endothelial cells: A link to atherosclerosis in patients with kidney disease
ERCAN OK, ALEXEI G BASNAKIAN, EUGENE O APOSTOLOV, YOUSRI M BARRI and SUDHIR V SHAH
Kidney Int 68: 173-178; doi:10.1111/j.1523-1755.2005.00391.x
Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat
WILLIAM J WELCH, MARGARIDA MENDONCA, JONATHAN BLAU, ALEX KARBER, KATHRYN DENNEHY, KINJAL PATEL, YUEN-SUM LAO, PEDRO A JOSÉ and CHRISTOPHER S WILCOX
Kidney Int 68: 179-187; doi:10.1111/j.1523-1755.2005.00392.x
Clinical Nephrology – Epidemiology – Clinical Trials
A novel type of encephalopathy associated with mushroom Sugihiratake ingestion in patients with chronic kidney diseases
FUMITAKE GEJYO, NORIYUKI HOMMA, NOBORU HIGUCHI, KEN ATAKA, TOMOKO TERAMURA, BASSAM ALCHI, YUKIO SUZUKI, SCHINICHI NISHI and ICHIEI NARITA THE JAPANESE SOCIETY of NEPHROLOGY
Kidney Int 68: 188-192; doi:10.1111/j.1523-1755.2005.00393.x
Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns
KASPER ROSSING, HARALD MISCHAK, HANS-HENRIK PARVING, PER K CHRISTENSEN, MICHAEL WALDEN, MEIKE HILLMANN and THORSTEN KAISER
Kidney Int 68: 193-205; doi:10.1111/j.1523-1755.2005.00394.x
Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease
PIERO RUGGENENTI, ANDREA REMUZZI, PATRIZIA ONDEI, GIORGIO FASOLINI, LUCA ANTIGA, BOGDAN ENE-IORDACHE, GIUSEPPE REMUZZI and FRANKLIN H EPSTEIN
Kidney Int 68: 206-216; doi:10.1111/j.1523-1755.2005.00395.x
C-reactive protein as predictor of death in end-stage diabetic nephropathy: Role of peripheral arterial disease
CARSTEN A BÖGER, ANGELA GÖTZ, MIKE STUBANUS, BERNHARD BANAS, MARTINA DEINZER, BERND KRÜGER, STEPHAN R HOLMER, GERD SCHMITZ, GÜNTER A J RIEGGER and BERNHARD K KRÄMER
Kidney Int 68: 217-227; doi:10.1111/j.1523-1755.2005.00396.x
Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study
TOSHIHARU NINOMIYA, YUTAKA KIYOHARA, MICHIAKI KUBO, YUMIHIRO TANIZAKI, YASUFUMI DOI, KEN OKUBO, YOSHIYUKI WAKUGAWA, JUN HATA, YOSHINORI OISHI, KENTARO SHIKATA, KOJI YONEMOTO, HIDEKI HIRAKATA and MITSUO IIDA
Kidney Int 68: 228-236; doi:10.1111/j.1523-1755.2005.00397.x
Biomarkers of inflammation and progression of chronic kidney disease
MARCELLO TONELLI, FRANK SACKS, MARC PFEFFER, GIAN S JHANGRI and GARY CURHAN FOR THE CHOLESTEROL AND RECURRENT EVENTS (CARE) TRIAL INVESTIGATORS
Kidney Int 68: 237-245; doi:10.1111/j.1523-1755.2005.00398.x
Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: Effect of long-term therapy with erythropoietin
ELENI C PAPAVASILIOU, CHARIKLIA GOUVA, KOSTAS C SIAMOPOULOS and ALEXANDROS D TSELEPIS
Kidney Int 68: 246-255; doi:10.1111/j.1523-1755.2005.00399.x
Identification of podocin (NPHS2) gene mutations in African Americans with nondiabetic end-stage renal disease
JUDITH A ENGELER DUSEL, KATHRYN P BURDON, PAMELA J HICKS, GREGORY A HAWKINS, DONALD W BOWDEN and BARRY I FREEDMAN
Kidney Int 68: 256-262; doi:10.1111/j.1523-1755.2005.00400.x
Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney
ESTER GONZÁLEZ, EDUARDO GUTIÉRREZ, ENRIQUE MORALES, EDUARDO HERNÁNDEZ, AMADO ANDRES, IGNACIO BELLO, RAFAEL DÍAZ-GONZÁLEZ, OSCAR LEIVA and MANUEL PRAGA
Kidney Int 68: 263-270; doi:10.1111/j.1523-1755.2005.00401.x
Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes
WAJEH Y QUNIBI, FADI ABOUZAHR, MOHAMMAD R MIZANI, CHARLES R NOLAN, RECTOR ARYA and KELLY J HUNT
Kidney Int 68: 271-277; doi:10.1111/j.1523-1755.2005.00402.x
Interleukin-1 gene cluster polymorphisms predict risk of ESRD
JAMES B WETMORE, ADRIANA M HUNG, DAVID H LOVETT, SAUNAK SEN, OMER QUERSHY and KIRSTEN L JOHANSEN
Kidney Int 68: 278-284; doi:10.1111/j.1523-1755.2005.00403.x
A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy
RAJIV AGARWAL, CHANDAN SAHA, MEHER BATTIWALA, NINA VASAVADA, TIMOTHY CURLEY, SHAWN D CHASE, NADINE SACHS and MERFAKE H SEMRET
Kidney Int 68: 285-292; doi:10.1111/j.1523-1755.2005.00416.x
Atherosclerotic renovascular disease in United States patients aged 67 years or older: Risk factors, revascularization, and prognosis
PHILIP A KALRA, HAIFENG GUO, ANNAMARIA T KAUSZ, DAVID T GILBERTSON, JIANNONG LIU, SHU-CHENG CHEN, AREEF ISHANI, ALLAN J COLLINS and ROBERT N FOLEY
Kidney Int 68: 293-301; doi:10.1111/j.1523-1755.2005.00406.x
Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy
AKI KUROKI, MASAYUKI IYODA, TAKANORI SHIBATA and TETSUZO SUGISAKI
Kidney Int 68: 302-310; doi:10.1111/j.1523-1755.2005.00415.x
Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 Study
AREEF ISHANI, ALLAN J COLLINS, CHARLES A HERZOG and ROBERT N FOLEY
Kidney Int 68: 311-318; doi:10.1111/j.1523-1755.2005.00414.x
Dialysis – Transplantation
Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients
YA-CHEN TINA SHIH, AMY GUO, PAUL M JUST and SALIM MUJAIS
Kidney Int 68: 319-329; doi:10.1111/j.1523-1755.2005.00413.x
Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS)
SUDITIDA SATAYATHUM, RONALD L PISONI, KEITH P MCCULLOUGH, ROBERT M MERION, BJORN WIKSTRÖM, NATHAN LEVIN, KENNETH CHEN, ROBERT A WOLFE, DAVID A GOODKIN, LUIS PIERA, YASUSHI ASANO, KIYOSHI KUROKAWA, SHUNICHI FUKUHARA, PHILIP J HELD and FRIEDRICH K PORT
Kidney Int 68: 330-337; doi:10.1111/j.1523-1755.2005.00412.x
Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease
CHRISTOPHER T CHAN, VIPAN JAIN, PETER PICTON, ANDREAS PIERRATOS and JOHN S FLORAS
Kidney Int 68: 338-344; doi:10.1111/j.1523-1755.2005.00411.x
Modifiable factors predicting patient survival in elderly kidney transplant recipients
HÉLOISE CARDINAL, MARIE-JOSÉE HÉBERT, ELHAM RAHME, ISABELLE HOUDE, DANA BARAN, MÉLANIE MASSE, ANNE BOUCHER and JACQUES LE LORIER THE ELDERLY RECIPIENTS TRANSPLANT GROUP
Kidney Int 68: 345-351; doi:10.1111/j.1523-1755.2005.00410.x
Skeletal muscle mRNA for IGF-IEa, IGF-II, and IGF-I receptor is decreased in sedentary chronic hemodialysis patients
HUIYUAN WANG, RICHARD CASABURI, WAYNE E TAYLOR, HESHAM ABOELLAIL, THOMAS W STORER and JOEL D KOPPLE
Kidney Int 68: 352-361; doi:10.1111/j.1523-1755.2005.00409.x
Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy
LESLIE P WONG, MOLLY P BLACKLEY, KENNETH A ANDREONI, HYUNSOOK CHIN, RONALD J FALK and PHILIP J KLEMMER
Kidney Int 68: 362-370; doi:10.1111/j.1523-1755.2005.00408.x
Different responses by cultured aortic and venous smooth muscle cells to gamma radiation
SEUNG-JUNG KIM, TAKAHISA MASAKI, ROY ROWLEY, JOHN K LEYPOLDT, SYED F MOHAMMAD and ALFRED K CHEUNG
Kidney Int 68: 371-377; doi:10.1111/j.1523-1755.2005.00407.x
Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis
RAJNISH MEHROTRA, DOUGLAS MARSH, EDWARD VONESH, VICKIE PETERS and ALLEN NISSENSON
Kidney Int 68: 378-390; doi:10.1111/j.1523-1755.2005.00453.x
Technical Note
Can murine diabetic nephropathy be separated from superimposed acute renal failure?
YUET-CHING TAY, YIPING WANG, LUKAS KAIRAITIS, GOPALA K RANGAN, CHUN ZHANG and DAVID C H HARRIS
Kidney Int 68: 391-398; doi:10.1111/j.1523-1755.2005.00405.x
Historical Archives
The use of the kidneys in secular and ritual practices according to ancient Greek and Byzantine texts
ATHANASIOS DIAMANDOPOULOS, ANDREAS SKARPELOS and GEORGIOS TSIROS
Kidney Int 68: 399-404; doi:10.1111/j.1523-1755.2005.00404.x
Editorials
Relaxin: Exploring the antifibrotic potential of a pregnancy hormone
JENS GAEDEKE and HARM PETERS
Kidney Int 68: 405-406; doi:10.1111/j.1523-1755.2005.00462.x
Vasculopathy and renal injury in lupus erythematosus: Does shedding of the endothelial protein C receptor play a role?
S JOSEPH LEIBOVICH
Kidney Int 68: 407-408; doi:10.1111/j.1523-1755.2005.00463.x
Letters to the Editor
Antiretroviral drugs and the kidney: Further precisions
HASSANE IZZEDINE, VINCENT LAUNAY-VACHER and GILBERT DERAY
Kidney Int 68: 409; doi:10.1111/j.1523-1755.2005.00455.x
Hypotonic fluids should not be used in volume-depleted children
MICHAEL L MORITZ and JUAN C AYUS
Kidney Int 68: 409-410; doi:10.1038/sj.ki.4496105
Active vitamin D agents and refractory hyperparathyroidism in dialysis patients
CARLO BASILE and CARLO LOMONTE
Kidney Int 68: 410; doi:10.1038/sj.ki.4496106
See also: Letter to the Editor byReply from the Authors
Kidney Int 68: 410-411; doi:10.1038/sj.ki.4496107
See also: Letter to the Editor by BASILE & LOMONTECombination of intravenous iron sucrose and ascorbic acid in hemodialysis patients
KENAN KEVEN, SIM KUTLAY, GOKHAN NERGIZOGLU and SEHSUVAR ERTURK
Kidney Int 68: 411; doi:10.1038/sj.ki.4496108
Continuous renal replacement therapy in the critically ill patient
ULRICH BINSWANGER
Kidney Int 68: 411-412; doi:10.1038/sj.ki.4496109
Herb-associated carcinogenicity and chronic renal failure in Asian patients with kidney cancer and hypertension
MING-YU LAI and WU-CHANG YANG
Kidney Int 68: 412; doi:10.1038/sj.ki.4496110
Dehydration versus volume depletion
MICHAEL EMMETT
Kidney Int 68: 412-413; doi:10.1038/sj.ki.4496111
Nephrology Forum
Ethnicity and renal disease
JOHN FEEHALLY Principal discussant:
Kidney Int 68: 414-424; doi:10.1111/j.1523-1755.2005.00454.x
